Satya Prakash

Dr. Satya Prakash ( is a Full Professor of Biomedical Engineering, Artificial Cells and Organs, Physiology, Experimental Medicine and Surgery in the Faculty of Medicine, at McGill University, Montreal, Quebec, Canada.

Dr. Prakash research interest includes microbiome, probiotics, biomedicine, cancer microencapsulation, targeted delivery of therapeutic molecules and other biomedical applications. Specifically, his team is developing biotherapeutics for use in cancer, coronary heart, liver, gastrointestinal and other diseases and develop novel wound healing device and next generation of cardiac stents.

Dr. Prakash is leading author of more than 300 research papers and several book chapters, research and other scholarly articles. His publication list includes 70 approved/pending patents and 3 edited books.

Dr. Prakash is the winner of more than 30 international awards including “Medial for Outstanding Contribution to the Advancement of Science”, Overseas Scholar, Fraser, Monat and McPherson Award, Canadian Institute of Health Research Investigator Award, FRSQ Chercheure‐Boursière and other awards.

Dr. Prakash is listed in editorial boards of several distinguished journals. He holds MSc, M. Tech (BHU, India) and a Ph.D. from McGill University, Montreal, Quebec, Canada.

Dr. Prakash is co-founder of MangoGen Pharma, Micropharma, and Proviva Pharma and currently serves as President, Director and various other positions.



The EuroBiotech Journal is the official journal of European Biotechnology Thematic Network Association (EBTNA), an international journal for scientists who work in the field of biotechnology.